Flk-1 receptor inhibitors of angiogenesis through tyrosine kinase: Update

Sugen Inc. (SUGN), Redwood City,

Read the full 50 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE